Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R
Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center New York, New York 10021, USA.
Cell. 1995 Aug 11;82(3):405-14. doi: 10.1016/0092-8674(95)90429-8.
The sphingomyelin pathway, which is initiated by sphingomyelin hydrolysis to generate the second messenger ceramide, signals apoptosis for tumor necrosis factor alpha, Fas, and ionizing radiation. In the present studies, the anticancer drug daunorubicin also stimulated ceramide elevation and apoptosis in P388 and U937 cells. Cell-permeable analogs of ceramide, but not other lipid second messengers, mimicked daunorubicin in inducing apoptosis. Daunorubicin-stimulated ceramide elevation, however, did not result from sphingomyelin hydrolysis, but rather from de novo synthesis via activation of the enzyme ceramide synthase. An obligatory role for ceramide synthase was defined, since its natural specific inhibitor, fumonisin B1, blocked daunorubicin-induced ceramide elevation and apoptosis. These studies demonstrate that ceramide synthase activity can be regulated in eukaryotes and constitute definitive evidence for a requirement for ceramide elevation in the induction of apoptosis.
鞘磷脂途径由鞘磷脂水解引发,生成第二信使神经酰胺,该途径介导肿瘤坏死因子α、Fas及电离辐射所引发的细胞凋亡。在本研究中,抗癌药物柔红霉素也可刺激P388和U937细胞中的神经酰胺水平升高并诱导细胞凋亡。神经酰胺的细胞可渗透类似物而非其他脂质第二信使,能够模拟柔红霉素诱导细胞凋亡。然而,柔红霉素刺激的神经酰胺水平升高并非由鞘磷脂水解所致,而是通过激活神经酰胺合酶从头合成产生。由于神经酰胺合酶的天然特异性抑制剂伏马菌素B1可阻断柔红霉素诱导的神经酰胺水平升高及细胞凋亡,因此确定了神经酰胺合酶的关键作用。这些研究表明,真核生物中神经酰胺合酶的活性可被调节,并且为诱导细胞凋亡过程中神经酰胺水平升高的必要性提供了确凿证据。